Addex Therapeutics Ltd. (ADXN) Non-Current Deffered Revenue (2023)
Addex Therapeutics' Non-Current Deffered Revenue history spans 1 years, with the latest figure at $100596.1 for Q4 2023.
- For Q4 2023, Non-Current Deffered Revenue changed N/A year-over-year to $100596.1; the TTM value through Dec 2023 reached $100596.1, changed N/A, while the annual FY2023 figure was $99354.8, N/A changed from the prior year.
- Non-Current Deffered Revenue for Q4 2023 was $100596.1 at Addex Therapeutics.
- Across five years, Non-Current Deffered Revenue topped out at $100596.1 in Q4 2023 and bottomed at $100596.1 in Q4 2023.